Earningsreport

Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus N/A ActVsEst N/A - N/A

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors